Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Donald Byrne, Ph.D., M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Byrne JD, Yeh JJ, DeSimone JM. Use of iontophoresis for the treatment of cancer. J Control Release. 2018 Aug 28; 284:144-151. PMID: 29908892.
    Citations:    Fields:    
  2. Byrne JD, Jajja MRN, O'Neill AT, Schorzman AN, Keeler AW, Luft JC, Zamboni WC, DeSimone JM, Yeh JJ. Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer. Cancer Chemother Pharmacol. 2018 06; 81(6):991-998. PMID: 29603014.
    Citations:    Fields:    
  3. Bowerman CJ, Byrne JD, Chu KS, Schorzman AN, Keeler AW, Sherwood CA, Perry JL, Luft JC, Darr DB, Deal AM, Napier ME, Zamboni WC, Sharpless NE, Perou CM, DeSimone JM. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer. Nano Lett. 2017 01 11; 17(1):242-248. PMID: 27966988.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  4. Byrne JD, Jajja MR, Schorzman AN, Keeler AW, Luft JC, Zamboni WC, DeSimone JM, Yeh JJ. Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A. 2016 Feb 23; 113(8):2200-5. PMID: 26858448.
    Citations: 1     Fields:    Translation:HumansAnimals
  5. Roberts RA, Eitas TK, Byrne JD, Johnson BM, Short PJ, McKinnon KP, Reisdorf S, Luft JC, DeSimone JM, Ting JP. Towards programming immune tolerance through geometric manipulation of phosphatidylserine. Biomaterials. 2015 Dec; 72:1-10. PMID: 26325217.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  6. Byrne JD, Jajja MR, O'Neill AT, Bickford LR, Keeler AW, Hyder N, Wagner K, Deal A, Little RE, Moffitt RA, Stack C, Nelson M, Brooks CR, Lee W, Luft JC, Napier ME, Darr D, Anders CK, Stack R, Tepper JE, Wang AZ, Zamboni WC, Yeh JJ, DeSimone JM. Local iontophoretic administration of cytotoxic therapies to solid tumors. Sci Transl Med. 2015 Feb 04; 7(273):273ra14. PMID: 25653220.
    Citations: 5     Fields:    Translation:HumansAnimals
  7. Xu J, Wong DH, Byrne JD, Chen K, Bowerman C, DeSimone JM. Future of the particle replication in nonwetting templates (PRINT) technology. Angew Chem Int Ed Engl. 2013 Jun 24; 52(26):6580-9. PMID: 23670869.
    Citations: 13     Fields:    Translation:Humans
  8. Dunn SS, Byrne JD, Perry JL, Chen K, Desimone JM. Generating Better Medicines for Cancer. ACS Macro Lett. 2013 Apr 24; 2(5):393-397. PMID: 23772351.
    Citations:    
  9. Wang Y, Byrne JD, Napier ME, DeSimone JM. Engineering nanomedicines using stimuli-responsive biomaterials. Adv Drug Deliv Rev. 2012 Aug; 64(11):1021-30. PMID: 22266128.
    Citations: 13     Fields:    
  10. Wang J, Byrne JD, Napier ME, DeSimone JM. More effective nanomedicines through particle design. Small. 2011 Jul 18; 7(14):1919-31. PMID: 21695781.
    Citations: 64     Fields:    Translation:Cells
  11. Parrott MC, Luft JC, Byrne JD, Fain JH, Napier ME, Desimone JM. Tunable bifunctional silyl ether cross-linkers for the design of acid-sensitive biomaterials. J Am Chem Soc. 2010 Dec 22; 132(50):17928-32. PMID: 21105720.
    Citations: 20     Fields:    Translation:Cells
  12. Betancourt T, Byrne JD, Sunaryo N, Crowder SW, Kadapakkam M, Patel S, Casciato S, Brannon-Peppas L. PEGylation strategies for active targeting of PLA/PLGA nanoparticles. J Biomed Mater Res A. 2009 Oct; 91(1):263-76. PMID: 18980197.
    Citations: 21     Fields:    Translation:Animals
  13. Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev. 2008 Dec 14; 60(15):1615-26. PMID: 18840489.
    Citations: 180     Fields:    Translation:HumansAnimals
  14. Fonner JM, Forciniti L, Nguyen H, Byrne JD, Kou YF, Syeda-Nawaz J, Schmidt CE. Biocompatibility implications of polypyrrole synthesis techniques. Biomed Mater. 2008 Sep; 3(3):034124. PMID: 18765899.
    Citations: 16     Fields:    
  15. Byrne JD, Baugh JA. The significance of nanoparticles in particle-induced pulmonary fibrosis. Mcgill J Med. 2008 Jan; 11(1):43-50. PMID: 18523535.
    Citations: 11     
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Byrne's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (86)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.